Our experience of solitary plasmacytoma of the bone: improved PFS with a short-course treatment by IMiDs or proteasome inhibitors combined with intensity-modulated radiotherapy.

Authors :: Le Ray E
Belin L
Plancher C
Anract P
Babinet A
Dumaine V
Tamburini J
Deau Fischer B
Willems L
Magro L
Facon T
Leleu X
Bouscary D
Kirova YM
Source :: Leukemia & lymphoma [Leuk Lymphoma] 2018 Jul; Vol. 59 (7), pp. 1756-1758. Date of Electronic Publication: 2017 Oct 31.
Publication Year :: 2018

Subjects :: Antineoplastic Combined Chemotherapy Protocols administration & dosage
Bone Neoplasms mortality
Combined Modality Therapy
Female
Humans
Kaplan-Meier Estimate
Male
Plasmacytoma mortality
Positron Emission Tomography Computed Tomography
Proteasome Inhibitors administration & dosage
Proteasome Inhibitors adverse effects
Treatment Outcome
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Bone Neoplasms diagnosis
Bone Neoplasms therapy
Plasmacytoma diagnosis
Plasmacytoma therapy
Proteasome Inhibitors therapeutic use
Radiotherapy, Intensity-Modulated methods

Full Text Access

Tools